KALA News and Press, Kala Pharmaceuticals Inc. From 09/14/20

Gainers:  Immunomedics (NASDAQ: IMMU ) +100% . More news on: Immunomedics, Inc., Cassava Sciences, Inc., Vaxart, Inc., Stocks on the move, , Read more ...

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will host a key opinion leader symposium on the unmet need in dry eye disease and the pote...

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that members of its management team will participate virtually in the following upcoming conferenc...

Kala Pharmaceuticals, Inc. (KALA) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Niranjan Kameswaran - SVP, Strategy Mary Reumuth - CFO Mark Iwicki - Chairman, President and CEO Kim Brazzell - Chief Medical Officer Todd Bazemore - COO Hon...

The following slide deck was published by Kala Pharmaceuticals, Inc. in conjunction with this Read more ...

Kala Pharmaceuticals (NASDAQ: KALA ) : Q2 GAAP EPS of -$0.42 misses by $0.01 . More news on: Kala Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

-- EYSUVIS™ NDA Accepted by FDA; Assigned PDUFA Goal Date of October 30, 2020 -- -- 2Q 2020 INVELTYS ® Revenue of $0.8 Million -- -- Conference Call and Webcast at 8:00 a.m. ET -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on ...

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference. Todd Bazemore, Chi...

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2020 financial results on Thursday, August 6, 2020. Management ...

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that its 2020 Annual Meeting of Stockholders (including any adjournments or postponements, the &#x...